ACHV Achieve Life Sciences Inc
Company Analysis
Latest News
Achieve's Smoking-Cessation Drug Posts Solid Quit Rates — But Can It Clear the FDA's Manufacturing Hurdle in Time?
Shares of Achieve Life Sciences surged 11.5% to $7.25 in pre-market trading on October 23, bucking a weaker broader market, after the company presented new...
🟢 Achieve Life Sciences is trading 11.5% up in pre-market after positive 52-week ORCA-OL trial results
Achieve Life Sciences is trading 11.5% up at $7.25 in pre-market on October 23, following positive 52-week ORCA-OL cytisinicline trial results announced...
🟢 Achieve Life Sciences is trading 6% up in pre-market
Achieve Life Sciences is trading at $7.00, up 5.98% pre-market; no fresh company announcement explaining the move was identified. - Achieve is set to present...
🟢 Achieve Life Sciences is trading 5.33% up — no company-specific catalyst identified
Achieve Life Sciences is trading 5.33% up at $6.72, with no company-specific announcement explaining the October 19 move surfaced in available reporting. -...
🔴 Achieve Life Sciences is trading 10% down today amid biotech sector weakness
Achieve Life Sciences is trading lower amid biotech sector weakness, at $6.27 (-10.04%). - XBI fell 2.06% during the regular session; the S&P 500 was down...
🔴 Achieve Life Sciences falls 5.9% — Biotech Sector Declines Amid Broad Market Rotation
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as represented by the XBI...
🟢 Achieve Life Sciences is trading 6.17% up in pre-market
Achieve Life Sciences is trading at $7.40, up 6.17% in pre-market; no clear company-specific catalyst has been identified. - The company’s news page shows no...
🔴 Achieve Life Sciences is trading 9.3% down in pre-market with no confirmed catalyst
Achieve Life Sciences is trading 9.3% down in pre-market at $6.35 on October 14, 2026, with no specific catalyst identified. - The previous close was $7.00. -...
🔴 Achieve Life Sciences is trading 5% down
Achieve Life Sciences is trading at $6.87, down 5.11%, with no confirmed October 5 company-specific catalyst. - Recent coverage centers on Benjamin Halladay...
🔴 Achieve Life Sciences is trading 5% down
Achieve Life Sciences is trading 5.05% down at $7.15; no confirmed company-specific news explains the October 2 decline. - Latest announcements were a CFO...
🟢 Achieve Life Sciences is trading 6% up in pre-market with no confirmed company-specific catalyst
Achieve Life Sciences is trading at $7.99, up 6.11% in pre-market, with no confirmed company-specific catalyst. - Broader U.S. indices were higher pre-market,...
Achieve Life Sciences Appoints Benjamin Halladay as New Chief Financial Officer
Achieve Life Sciences announced the appointment of Benjamin Halladay as its new Chief Financial Officer (CFO), effective October 5, 2026. Mr. Halladay will...
🔴 Achieve Life Sciences is trading 5% down — no company-specific catalyst identified
Achieve Life Sciences is trading at $7.68, down 5.07%; no company-specific announcement explained the October 1 decline. - Latest identified news was an...
🟢 Achieve Life Sciences is trading 7% up as catalyst remains unclear
Achieve Life Sciences is trading 6.76% higher at $8.21, with no confirmed company-specific announcement explaining the move. - Its latest identified company...
🔴 Achieve Life Sciences is trading 6.77% down in pre-market with no clear company-specific catalyst identified
Achieve Life Sciences is trading 6.77% lower at $7.30, with no clear company-specific announcement identified for September 25, 2026. - The decline contrasts...
🟢 Achieve Life Sciences is trading 5% up in pre-market amid broader risk-on sentiment
Achieve Life Sciences is trading at $8.40 (+5.26%), apparently amid broader risk-on sentiment. - No new company-specific announcement was identified for...
🟢 Achieve Life Sciences is trading 5% up today as U.S. equities rally
Achieve Life Sciences is trading 5.26% up now at $7.81 as U.S. equities rally. - The S&P 500 is up 0.91%, while the Nasdaq Composite is up 1.27%. - The...
🔴 Achieve Life Sciences is trading 5% down today as risk-off sentiment pressures equities
Achieve Life Sciences is trading at $8.05, down 5.12%, amid a weaker September 8, 2026 market backdrop, including risk-off sentiment, higher oil prices,...
Frazier Life Sciences Takes 7.4% Stake in Achieve, Backing Nicotine Treatment
Frazier Life Sciences Management L.P. purchased 7,614,836 shares of Achieve Life Sciences. This investment establishes a 7.40% ownership position in the...
🟢 Achieve Life Sciences is trading 5% up today despite weaker broader markets and biotech
Achieve Life Sciences is trading at $8.35, up +5.16%, though the specific reason for the intraday increase remains unclear. - No major company-specific...